BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 12:36:00 PM | Browse: 615 | Download: 479
Publication Name World Journal of Radiology
Manuscript ID 9641
Country/Territory Italy
Received
2014-02-22 11:29
Peer-Review Started
2014-02-22 20:23
To Make the First Decision
2014-04-04 16:11
Return for Revision
2014-04-09 10:28
Revised
2014-04-21 00:49
Second Decision
2014-05-29 15:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-29 16:00
Articles in Press
2014-05-29 16:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-06-11 16:10
Typeset the Manuscript
2014-07-11 15:47
Publish the Manuscript Online
2014-07-31 11:53
ISSN 1949-8470 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac and Cardiovascular Systems
Manuscript Type Minireviews
Article Title Nuclear imaging in detection and monitoring of cardiotoxicity
Manuscript Source Invited Manuscript
All Author List Carmen D’Amore, Paola Gargiulo, Stefania Paolillo, Angela Maria Pellegrino, Tiziana Formisano, Antonio Mariniello, Giuseppe Della Ratta, Elisabetta Iardino, Marianna D’Amato, Lucia La Mura, Irma Fabiani, Flavia Fusco and Pasquale Perrone Filardi
Funding Agency and Grant Number
Corresponding Author Pasquale Perrone Filardi, MD, PhD, Department of Advanced Biomedical Sciences, Federico II University, Via Pansini, 5, 80131 Naples, Italy. fpperron@unina.it
Key Words Cardiotoxicity; Cardiac nuclear imaging; Early diagnosis; Scintigraphy; Positron emission tomography
Core Tip Cardiomyopathy is a potential complication of various anticancer drugs, such as anthracyclines and biological therapy. Left ventricular dysfunction is the most common manifestation of cardiotoxicity and is monitored with left ventricular ejection fraction measurement, but it is a late manifestation of myocardial injury. Thus, the cardiologist and oncologist should collaborate to identify new non-invasive techniques to detect cardiac dysfunction at an early and potentially reversible stage, before the onset of clinical manifestation. To achieve this aim, nuclear imaging techniques may offer good future perspectives for early detection of myocardial damage using novel molecular tracers.
Publish Date 2014-07-31 11:53
Citation D’Amore C, Gargiulo P, Paolillo S, Pellegrino AM, Formisano T, Mariniello A, Della Ratta G, Iardino E, D’Amato M, La Mura L, Fabiani I, Fusco F, Perrone Filardi P. Nuclear imaging in detection and monitoring of cardiotoxicity. World J Radiol 2014; 6(7): 486-492
Url http://www.wjgnet.com/1949-8470/full/v6/i7/486.htm
DOI http://dx.doi.org/10.4329/wjr.v6.i7.486
Full Article (PDF) WJR-6-486.pdf
Full Article (Word) WJR-6-486.doc
Manuscript File 9641-Review.docx
Answering Reviewers 9641-Answering reviewers.pdf
Copyright License Agreement 9641-Copyright assignment.pdf
Peer-review Report 9641-Peer review(s).pdf
Scientific Misconduct Check 9641-CrossCheck.jpg
Scientific Editor Work List 9641-Scientific editor work list.pdf